Fresenius Wins U.S. Appeal Over Baxter Hemodialysis PatentSusan Decker
Fresenius Medical Care AG won a U.S. appeals court ruling today that will end a patent-infringement claim brought against it by Baxter International Inc. over kidney dialysis machines.
The U.S. Patent and Trademark Office has canceled the Baxter patent after a review while the civil suit was still pending, so there is no longer any basis for Baxter’s claim, the U.S. Court of Appeals for the Federal Circuit ruled in Washington today. The opinion was posted on the court’s website.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.